MedTech Panel Summary: Strategic Uses of Real World Evidence to Demonstrate Value

October 2019

On September 25, Discern Health Partner Tom Valuck moderated the expert panel “Strategic Use of Post-Market Real World Evidence (RWE) to Demonstrate Value” during MedTech 2019 in Boston, MA. The panel was composed of health care data analytics and RWE innovation experts from The OCI Group, LLC; Milliman, Inc.; and Archimedic.

The presentation focused on applications of RWE to quality measurement, value-based payment, and coverage and raised issues of interest for the medical device community, such as the potential use of clinical trial and Food and Drug Administration-mandated surveillance data to demonstrate value for payment and coverage.

Download a summary of the panel presentation here.

For more information, please contact Gracelena Ignacio at gignacio@discernhealth.com.

Discern expands Health Economics and Outcomes Research (HEOR) Capabilities For Life Sciences clients

Health economics and outcomes research (HEOR) has long been important for health care market access outside the U.S., but it is increasingly being utilized in the U.S. as part of the movement from vol...
Learn More

About

About

Capabilities

Capabilities

Contact

Contact Us

Insights

Insights

Guy D’Andrea Speaks About Innovative Payment Models

Click here to view the VIDEO